The foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers

15 - 16 May 2018

Corinthia Saint-Petersburg Hotel

First speaker confirmations in 2018:

Dmitry Rozhdestvensky, Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation, Eurasian Economic Commission
Dmitry Rozhdestvensky

Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation

Eurasian Economic Commission

Anthony Wong, Regional Vice-President, Russia, Ukraine & CIS, AbbVie
Anthony Wong

Regional Vice-President, Russia, Ukraine & CIS

AbbVie

Matthias Wernicke, General Manager, Merck Biopharma Russia and CIS.
Matthias Wernicke

General Manager

Merck Biopharma Russia and CIS.

Sergei Zakharov, Chairman of the Board & Managing Partner, Marathon Group
Sergei Zakharov

Chairman of the Board & Managing Partner

Marathon Group

Vikram Singh Punia, President, Pharmasyntez
Vikram Singh Punia

President

Pharmasyntez

Dmitry  Efimov, Senior Vice-President for Russia, CIS and South-Eastern Europe, STADA
Dmitry Efimov

Senior Vice-President for Russia, CIS and South-Eastern Europe

STADA

Vladimir Khristenko, President, Nanolek
Vladimir Khristenko

President

Nanolek

Mikhail Nekrasov, General Director, Nanolek
Mikhail Nekrasov

General Director

Nanolek

Alexander Kuzin, Managing Director, NovaMedica
Alexander Kuzin

Managing Director

NovaMedica

Igor Krylov, Chief Operations Officer, Marathon Pharma
Igor Krylov

Chief Operations Officer

Marathon Pharma

Dmitriy Morozov, Chairman of the Board of Directors, Biocad
Dmitriy Morozov

Chairman of the Board of Directors

Biocad

Alina Lavrentieva, Head of Pharmaceutical Industry Practice, PwC
Alina Lavrentieva

Head of Pharmaceutical Industry Practice

PwC

Andrey Odabashian, Head of Legal Services to Pharmaceutical Companies, PwC Legal
Andrey Odabashian

Head of Legal Services to Pharmaceutical Companies

PwC Legal

Sergey Piven, President, SIA Group
Sergey Piven

President

SIA Group

Andrey Gusev, General Director, Mega Pharm
Andrey Gusev

General Director

Mega Pharm

Alexander Sergeyev, Executive Director, Biocom
Alexander Sergeyev

Executive Director

Biocom

Vladislav Shestakov, Director, Federal State Institution
Vladislav Shestakov

Director

Federal State Institution "State Institute of Drugs and Good Practices" of the Ministry of Industry and Trade of the Russian Federation

Vladimir Shipkov, Executive Director, AIPM Russia
Vladimir Shipkov

Executive Director

AIPM Russia

Lilia Titova, Executive Director, The Union of Professional Pharmaceutical Organizations (SPFO)
Lilia Titova

Executive Director

The Union of Professional Pharmaceutical Organizations (SPFO)

Andrey Ahantiev, Economic Security Director, GEROPHARM
Andrey Ahantiev

Economic Security Director

GEROPHARM

Yury Krestinsky, Director, Research Centre for Economics and Management in Healthcare, Moscow School of Management SKOLKOVO
Yury Krestinsky

Director, Research Centre for Economics and Management in Healthcare

Moscow School of Management SKOLKOVO

Elena Popova, Senior Director Regulatory Affairs & Healthcare Policy, AIPM Russia
Elena Popova

Senior Director Regulatory Affairs & Healthcare Policy

AIPM Russia

Almira Galeeva, Director of Clinical Research & Medical Affairs, AIPM Russia
Almira Galeeva

Director of Clinical Research & Medical Affairs

AIPM Russia

Vadim Kukava, Executive Director, Association of Pharmaceutical Companies “Innovative Pharma”
Vadim Kukava

Executive Director

Association of Pharmaceutical Companies “Innovative Pharma”

Benjamin Munblit, Director of Analytics and Consultancy Department, Ipsos Healthcare
Benjamin Munblit

Director of Analytics and Consultancy Department

Ipsos Healthcare

The Programme 2018 includes:

  • Labelling of medicines in Russia
  • GMP inspections
  • State procurement of pharmaceutical drugs: VED list, price setting & the introduction of an information and analytical monitoring and control system
  • Manufacturing of pharmaceutical drugs in Russia: implementation of the import substitution programme in the pharmaceutical industry, obtaining a special investment contract & contract manufacturing
  • Protection of intellectual property rights for pharmaceutical drugs: issues and international practice
  • Search for innovations through partnerships: analysis of opportunities and challenges in the global market
  • Development of a common pharmaceutical market in the EAEU: problems of formation and future prospects
  • Digitalisation in the pharmaceutical industry: prospects for telemedicine and development of innovative medical technologies
  • Changes in the retail market: consolidation of pharmacy chains, prospects for pharmaceutical sales via the Internet and supermarkets
    and many more!
grac2283 1

 

 

 

View Picture Gallery
from the Russian Pharmaceutical Forum 2017

 

 

 

View highlights video
from the Russian Pharmaceutical Forum 2017

 

More videos, including interviews with speakers HERE >>>

Amongst 600+ PARTICIPANTS:

Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare

Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals

Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences

WHY TO ATTEND THE RUSSIAN PHARMACEUTICAL FORUM?

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

Sponsored by:

Supporting organisations